T A Thomson

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. ncbi Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
    Steven Jm Jones
    Genome Sciences Centre, British Columbia Cancer Agency, 570 West 7th Avenue, Vancouver, BC, V5Z 4S6, Canada
    Genome Biol 11:R82. 2010
  2. ncbi Cytogenetic and cytologic features of chondroid lipoma of soft tissue
    T A Thomson
    Department of Laboratory Medicine, British Columbia Cancer Agency, Vancouver Clinic, Canada
    Mod Pathol 12:88-91. 1999
  3. ncbi HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization
    T A Thomson
    Department of Laboratory Medicine, BC Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6
    Mod Pathol 14:1079-86. 2001

Collaborators

  • Steven Jm Jones
  • Richard A Moore
  • Inanc Birol
  • Nataliya Melnyk
  • Malachi Griffith
  • Timothee Cezard
  • Margaret Sutcliffe
  • Montgomery Martin
  • Marco A Marra
  • Tesa Severson
  • Thomas Zeng
  • Janessa Laskin
  • Obi L Griffith
  • Anthony P Fejes
  • Ryan D Morin
  • Yaron S Butterfield
  • Michael Mayo
  • Eric Chuah
  • Sohrab P Shah
  • Jefferson Terry
  • John Yee
  • Trevor J Pugh
  • Angela Tam
  • Yongjun Zhao
  • Jianghong An
  • David G Huntsman
  • Mikhail Bilenky
  • Richard Corbett
  • Martin Hirst
  • Yvonne Y Li
  • Robert A Holt
  • Richard Varhol
  • Nina Thiessen

Detail Information

Publications3

  1. ncbi Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
    Steven Jm Jones
    Genome Sciences Centre, British Columbia Cancer Agency, 570 West 7th Avenue, Vancouver, BC, V5Z 4S6, Canada
    Genome Biol 11:R82. 2010
    ..We investigated the utility of massively parallel sequencing to characterize an adenocarcinoma of the tongue, before and after treatment...
  2. ncbi Cytogenetic and cytologic features of chondroid lipoma of soft tissue
    T A Thomson
    Department of Laboratory Medicine, British Columbia Cancer Agency, Vancouver Clinic, Canada
    Mod Pathol 12:88-91. 1999
    ..The 11q13 breakpoint was previously noted in hibernomas, raising the possibility of a common genetic deregulation...
  3. ncbi HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization
    T A Thomson
    Department of Laboratory Medicine, BC Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6
    Mod Pathol 14:1079-86. 2001
    ..In cases with stain intensity of +1 or +2, the interobserver agreement is poor, and the predictive value is unsatisfactory for clinical use. Additional testing, preferably with FISH, is recommended...